Morgan Stanley Upgrades HCP to Equal-Weight

Brokerage firm Morgan Stanley Upgrades its rating on HCP(HCP). The shares have been rated Equal-Weight. Previously, the analysts had a Underweight rating on the shares. The rating by the stock financial advisor at Morgan Stanley was issued on Mar 20, 2017 in a research report to their Investors and Clients.

In a different note, Baird said it Initiates Coverage On HCP, according to a research note issued on Mar 10, 2017. In the research note, the firm Announces the price-target to $32 per share. The shares have been rated ‘Neutral’ by the firm. On Jan 25, 2017, Goldman Sachs said it Upgrades its rating on HCP. According to the research note, Goldman Sachs Raises the price target to $35 per share from a prior target of $29. The shares have been rated ‘Buy’ by the firm.

HCP (HCP) made into the market gainers list on Wednesdays trading session with the shares advancing 1.60% or 0.48 points. Due to strong positive momentum, the stock ended at $30.49, which is also near the day’s high of $30.65. The stock began the session at $30.11 and the volume stood at 70,17,073 shares. The 52-week high of the shares is $36.50149 and the 52 week low is $27.61. The company has a current market capitalization of $14,282 M and it has 46,84,14,990 shares in outstanding.

HCP(HCP) last announced its earnings results on Feb 13, 2017 for Fiscal Year 2016 and Q4.Company reported revenue of $539.950M. Analysts had an estimated revenue of $527.100M. Earnings per share were $0.59. Analysts had estimated an EPS of $0.26.

Several Insider Transactions has been reported to the SEC. On Mar 16, 2017, Scott A Anderson (EVP and CAO) sold 10,000 shares at $29.94 per share price.Also, On Jan 31, 2017, Thomas Klaritch (Senior Managing Director) sold 16,519 shares at $40.15 per share price.On Sep 8, 2016, Thomas D Kirby (Executive Vice President) sold 3,000 shares at $40.24 per share price, according to the Form-4 filing with the securities and exchange commission.

HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.

Add Comment